VALENS
Live / Applied — Statement of use — registration review complete (as of 05 Oct 2026)
What this means for you
Not registered yet, but its 22 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98463155
- Mark type
- Word mark
- Filed
- 22 Mar 2024
- Published for opposition
- 31 Dec 2024
- Attorney of record
- William C. Wright
Goods and services
- Class 001 — Chemicals: Excipients for use in the manufacture of injectable drugs; Excipients for use in the manufacture of vaccines; Excipients and active chemical ingredients for use in development, formulation and manufacture of vaccines and injectable formulations
- Class 005 — Pharmaceuticals: Adjuvants for medical purposes; Adjuvants for use in pharmaceutical preparations; Adjuvants for use with vaccines;
Owner
- SPI Pharma, Inc., Wilmington, DE, US
- SPI Pharma, Inc., Wilmington, DE, US
Prosecution history
- 05 Oct 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Oct 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Sept 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Aug 2026 — USE AMENDMENT FILED
- 24 Aug 2026 — TEAS STATEMENT OF USE RECEIVED
- 10 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Feb 2026 — SOU EXTENSION 2 GRANTED
- 10 Feb 2026 — SOU EXTENSION 2 FILED
- 10 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 23 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jul 2025 — SOU EXTENSION 1 GRANTED
- 23 Jul 2025 — SOU EXTENSION 1 FILED
- 23 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 31 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED